WereMed – Praxis für Innere Medizin
Termin

PD Dr. med. Renate Weber

Publikationen

Zahlreiche begutachtete Fachartikel in renommierten internationalen Zeitschriften, Buchbeiträge und Kongressbeiträge.

Publikationsverzeichnis

Filtern Sie die Veröffentlichungen nach Fachzeitschriften, Buchbeiträgen oder Kongressbeiträgen.

2020er

Auswirkungen des Post-COVID-Syndroms auf die VO2max und ihre Folgen für die Rehabilitationsplanung: Einblicke aus der Spiroergometrie-Analyse

Weber Renate M., Weber J., Kwon Y., Reichelt Y.

DEGAM, Würzburg 2024 (2024)

Prävalenz des obstruktiven Schlafapnoe-Syndroms bei Patienten mit Komorbiditäten: Einblicke aus den Disease-Management-Programmen

Weber Renate M., Weber J., Kwon Y., Reichelt S.

DGSM Essen, 2024 (2024)

Metastasiertes Pankreaskarzinom: individualisierte zielgerichtete molekulare und Immuncheckpoint-Therapie führt zu signifikanter Tumorkontrolle

Weber Renate M., Weber J., Staiger A.

DGHO, Basel 2024 (2024)

2010er

P680 Onkologie in der Primärmedizin / Oncology in primary medicine

Weber Renate M., Martyn S.

DGHO, Berlin, Germany (2019)

C-kit (CD 117) expression in human tumors and its prognostic value: an immunohistochemical analysis

Medinger M., Kleinschmidt M., Mross K., Wehmeyer B., Unger C., Schaefer HE, Weber R., Azemar M.

Pathol Oncol Res, 16(3):295-301 (2010)

IF 1.9
2000er

Regenerative and cell therapy: clinical advances

Keating A., Gorin C., Dicke C., Weber RM, Graf H.

Springer (2004)

C102: a novel STAT3 transcription factor interacting protein

Gabler A., Ho A.D., Weber RM

Dissertation (2004)

Receptor tyrosine kinases: the main targets for new anticancer therapy

Drevs J., Medinger M., Schmidt-Gersbach C., Weber R., Unger C.

Curr Drug Targets, 4(2):113-21 (2003)

IF 3.5

Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells

Winter A., Breit S., Parsch D., Benz K., Steck E., Hauner H., Weber RM, Ewerbeck V., Richter W.

Arthritis Rheum, 48:418-29 (2003)

IF 9

Addition of a low fixed number of CD3+ cells to CD34-enriched allograft effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation

Goerner M., Weber-Nordt R., Hoepfner S., Benner A., Luft T., Ho AD

J Hematother Stem Cell Res, 12:309-20 (2003)

IF 3.18

Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine

Goerner M., Kordelas L., Thalheimer M., Luft T., Pfeiffer S., Ustaoglu F., Punzel M., Weber-Nordt R., Moos M., Goldschmidt H., Ho AD

Bone Marrow Transplant, 29:621-4 (2002)

IF 3.8

Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia

Abdallah A., Egerer G., Weber-Nordt RM, Korbling M., Haas R., Ho AD

Bone Marrow Transplant, 30:15-22 (2002)

IF 3.8

Less intense conditioning with Fludarabine, Cyclophosphamide, Idarubicin and Etoposid (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

Schlenk R., Hartmann F., Hensel M., Jung W., Weber-Nordt R., Gabler A., Moos M., Haas R., Ho A.D., Trümper L., Döhner H.

Leukemia, 16:581-6 (2002)

IF 12.1

C102: A novel STAT3 interaction partner

Gabler A., Doostdar L., Ho A.D., and Weber-Nordt R.M.

DGHO, Graz, Österreich (2000)

ATRA syndrome: radiological findings in AML, M3 patients during induction therapy

Weber-Nordt R.M., Heß T. and Ho A.D.

DGHO, Graz, Österreich (2000)

T-cell addback in recurrent AML after stem cell transplantation

Weber-Nordt R.M., Görner M., Thalheimer M., Goldschmidt H., Moos M. and Ho A.D.

DGHO, Graz, Österreich (2000)

Allogeneic transplantation of T-cell depleted stem cell grafts

Weber-Nordt R.M., Thalheimer M., Görner M., Punzel M., Goldschmidt H. and Ho A.D.

DGHO, Graz, Österreich (2000)

Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation

Leo A., Mytilineos J., Voso M.T., Weber-Nordt R., Liebisch P., Lensing C., and Schraven B.

Transfusion, 40:632-636 (2000)

IF 0.17

Stem cells from umbilical cord blood

Weber-Nordt R.M.

Biomedical Progress, 13:6-9 (2000)

IF 1.8
1990er

Constitutive STAT3-DNA binding activity coincides with a single amino acid exchange in the aminoterminal domain of the STAT3 protein in acute myeloid leukemia

Weber-Nordt R.M., Janson C., Gabler A., and Ho A.D.

Blood, supplement (1999)

Patentschrift "Interaktionsproteine für STAT Transkriptionsfaktor"

Weber-Nordt R.M., Gabler A.

1999

Stammzellen aus Nabelschnurblut

Weber-Nordt R.M.

Die gelben Hefte, 4:105-111 (1999)

STAT dependent gene transcription in leukemic cells

Weber-Nordt R.M., Homburger L., Gabler A., Wehinger J., Finke J., and Ho A.D.

DGHO, Frankfurt, Germany (1998)

STAT transcription factors are constitutively activated in leukemic cells

Weber-Nordt R.M., Egen C., Wehinger J., Finke J., and Ho A.D.

Cancer Detection and Prevention, Nizza (1998)

The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation

Weber-Nordt R.M., Mertelsmann R., and Finke J.

Leukemia & Lymphoma, 28:459-467 (1998)

IF 3

Inhibition of STAT5 phosphorylation leads to a decrease in the proliferative response of leukemia cells

Weber-Nordt R.M., Wehinger J., Egen C., Mertelsmann R., and Finke J.

IACRLRD-Symposium (1997)

Analyses of in vitro expanded progenitor cells from cord blood: function and phenotype

Weber-Nordt R.M., Schriever Th., Dengler E., Mertelsmann R., and Finke J.

Int. Soc. Haematology (1997)

Analysis of a regulatory element in the 5'-untranslated region of bcl-2

Körner I., Weber-Nordt R., Pfaff P., and Finke J.

FEBS Letters, 406:31-32 (1997)

IF 3.1

Inhibition of STAT-protein phosphorylation decreases proliferation in murine and human leukemia cells

Weber-Nordt R.M., Wehinger J., Egen C., Mertelsmann R., and Finke J.

Blood, 88:3172 (1996)

FAS and FAS Ligand expression in human leukemias and lymphomas

Weber-Nordt R.M., Lang S., Mertelsmann R., and Finke J.

Blood, 88:3171 (1996)

Cord blood banking: practical and hematological issues

Weber-Nordt R.M., Schott E., Schriever T., Zahradnik H.-P., Schulz G., Finke J., and Mertelsmann R.

DGHO, Oktober 1996 (1996)

STAT transcription factors are constitutively activated in acute leukemia cells

Weber-Nordt R.M., Egen C., Wehinger J., Preßler A., Mertelsmann R., and Finke J.

DGHO, Oktober 1996 (1996)

Constitutive activation of STAT proteins in primary human leukemia cells

Weber-Nordt R.M., Egen C., Wehinger J., Mertelsmann R., and Finke J.

American Association of Immunology, May 1996 (1996)

Placental Blood: New options in hematopoietic stem cell transplantation

Weber-Nordt R.M. and Mertelsmann R.

Schering Research Foundation Workshop 20, p: 25-36 (1996)

Umbilical Cord Blood: an alternative to the transplantation of bone marrow stem cells

Weber-Nordt R.M., Schott E., Finke J., Henschler R., Schulz G., and Mertelsmann R.

Cancer Treatment Reviews, 22:381-391 (1996)

IF 8.8

Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors

Finke J., Brugger W., Bertz H., Behringer D., Kunzmann R., Weber-Nordt R.M., Kanz L., and Mertelsmann R.

Bone Marrow Transplantation, 18:1081-1086 (1996)

IF 3.8

IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes

Wehinger J., Mertelsmann R., and Weber-Nordt R.M.

FEBS Letters, 394:365-370 (1996)

IF 3.1

STAT related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients

Gouilleux-Gruart V., Gouilleux F., Desaint C., Claisse J.-F., Capoid J.-C., Delobel J., Weber-Nordt R., Dusanter-Fourt I., Dreyfus F., Groner B., and Prin L.

Blood, 87:1692-1697 (1996)

IF 10.6

Basal activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr-Virus (EBV) related lymphoma cell lines

Weber-Nordt R.M., Egen C., Wehinger J., Mertelsmann R., and Finke J.

Blood, 88:809-816 (1996)

IF 10.6

IL-10 increases Bcl-2 expression in primary human CD34+ hematopoietic progenitor cells

Weber-Nordt R.M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R., and Finke J.

Blood, 88:2549-2558 (1996)

IF 10.6

Stat3 Recruitment by two distinct ligand induced tyrosine phosphorylated docking sites in the IL-10 receptor intracellular domain

Weber-Nordt R.M., Greenlund A.C., Riley J.K., Moore K.W., Darnell J.E., and Schreiber R.D.

J. Biol. Chem., 271:27954-27961 (1996)

IF 4.1

Basal activation of Stat proteins in primary human ALL cells

Weber-Nordt R.M., Wehinger J., Egen C., Mertelsmann R., and Finke J.

Am. Soc. Hematol., Dec. 1995 (1995)

IL-10 increases Bcl-2 expression in primary human CD34+ hematopoietic progenitor cells derived from bone marrow or peripheral blood

Weber-Nordt R.M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R., and Finke J.

Am. Soc. Hematol., Dec. 1995 (1995)

Expression of Apoptosis modulating genes is differentially regulated during myeloid development from multipotent hematopoietic progenitor cells

Weber-Nordt R.M., Schott E., Finke J., Mertelsmann R., and Henschler R.

DGHO, Oktober 1995 (1995)

IL-10 rescues Bone Marrow and Blood derived human CD34+ Cells from Cell Death induced by Bcl-2 deprivation

Weber-Nordt R.M., Behringer D., Schott E., Henschler R., Mertelsmann R., and Finke J.

DGHO, Oktober 1995 (1995)

Interaction of IL-10 with its receptor leads to the activation of STAT1, STAT3, and STAT5 and the formation of multiple DNA binding complexes

Weber-Nordt R.M., Wehinger J., Gouilleux F., Groner B., Henschler R., and Mertelsmann R.

DGHO, Oktober 1995 (1995)

Expression of Apoptosis modulating genes during myeloid maturation in multipotent hematopoietic progenitor FDCPmix Cells

Weber-Nordt R.M., Schott E., Finke J., Mertelsmann R., and Henschler R.

Internat. Soc. Exp. Hematol., August 1995 (1995)

IL-10 activates Stat1 and Stat3

Weber-Nordt R.M., Greenlund A.C., Moore K.W., Darnell J.E. and Schreiber R.D.

Experimental Biology (AAI), April 1995 (1995)

Interleukin-10: Stat1 und Stat3 Phosphorylierung vermittelt intrazelluläre Signaltransduktion

Weber-Nordt R.M., Greenlund A.C. und Schreiber R.D.

101. Tagung der Deutschen Gesellschaft für Innere Medizin, 23.-26. April 1995 (1995)

Expression of apoptosis modulating genes during myeloid maturation in FDCPmix multipotent hematopoietic progenitor cells

Weber-Nordt R.M., Schott E., Finke J., Mertelsmann R., and Henschler R.

Exp. Hematol., supplement (1995)

IF 2.8

Hematopoietic cell proliferation and hematopoietic growth factors

Weber-Nordt R., Mertelsmann R., and Henschler R.

Current Opin. Hematol., 2:309-321 (1995)

IF 2.8

Interleukin-12 Signaling in T Helper Type 1 (Th1) Cells Involves Tyrosine Phosphorylation of Signal Transducer and Activator of Transcription (Stat)3 and Stat4

Jakobson N.G., Szabo S.J., Weber-Nordt R.M., Zhong Z., Schreiber R.D., Darnell J.E., and Murphy K.M.

J. Exp. Med., 181:1755-1762 (1995)

IF 10.8

Interaction of IL-10 with its receptor leads to the activation of STAT1 and STAT3 and the formation of multiple DNA binding complexes

Weber-Nordt R.M., Darnell J.E., and Schreiber R.D.

Am. Soc. Cell Biol. (1994)

IL-10 induces STAT1 and STAT3 Activation in cells

Weber-Nordt R.M., Greenlund A.C., Darnell J.E., and Schreiber R.D.

Blood 84 (Suppl 1):878 (1994)

Interaction of IL-10 with its receptor leads to the activation of STAT1 and STAT3

Weber-Nordt R.M., Darnell J.E., and Schreiber R.D.

Conference of the NY Acad. Sci. on "Receptor Activation by Antigens, Cytokines, Hormones and Growth Factors" (1994)

LPS induces IL-10 Receptors on Murine Fibroblasts

Weber-Nordt R.M., Ho A.S.Y., Moore K.W., and Schreiber R.D.

FASEB J. 8:A1314 (1994)

LPS-Dependent Induction of IL-10 Receptor Expression on Murine Fibroblasts

Weber-Nordt R.M., Meraz M.A., and Schreiber R.D.

J. Immunol., 153:3734-3544 (1994)

IF 4.7

LPS induces expression of IL-10 binding sites on murine fibroblasts

Weber-Nordt R.M., Meraz M.A., Schreiber R.D.

J. Immunol. 150:II-717 (1993)

A bispecific antifibrin/antiplatelet urokinase conjugate enhances plasminogen activation at both targets

Bode C., Nordt T.K., Runge M.S., Ruef J., Weber R., Wein M., Haber E.

J. Am. Coll. Cardiol. 19:393A (1992)

Therapeutische Möglichkeiten, respektive Implikationen bei stummer Ischämie

Kübler W., Hoberg E., Weber R.

Z Kardiologie, 81:193-198 (1992)

IF 0.04

The extend of platelet aggregability after coronary thrombolysis in man depends on the choice of plasminogen activator

Nordt T.K., Gries A., Arens M., Baumann H., Weber R., Bode C.

Circulation 84 (Suppl II):II-515 (1991)

Was ist gesichert in der thrombolytischen Therapie des akuten Myokardinfarktes?

Bode C., Weber R., von Hodenberg E., Kübler W.

Internist, 32:665-673 (1991)

IF 0.4

Entwicklung humaner monoklonaler Antikörper nach in vitro Immunisierung menschlicher Milzlymphozyten mit Mammakarzinomzellen

Weber Renate

Dissertation, Heidelberg, 130 Seiten (1991)

1980er

In-vitro Immunisierung menschlicher Milzlymphozyten mit Mammakarzinomzellen

Weber R., Kaul S., Bastert G.

Klinische Tumorimmunologie in der Gynäkologie. Zuckschwerdt, München (1989)

Zurück zur Ärztlichen Leitung

Patientenportal

Zugang zu Ihren Daten

Befunde einsehen, Termine verwalten, Dokumente abrufen.

Zum Portal